DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/6201| Title: | Kallidinogenase (Tissue Kallikrien) in Complex Therapy in Patients with Isolated Closed Traumatic Brain Injury |
| Authors: | Аvakov V. E., Ibragimov N. K., Murotov TM. N. |
| Keywords: | CTBI, Tissue kallikrein (kallidinogenase), ICP, CPP, GLASGOW scale, SAPS II, APACHE II |
| Issue Date: | 4-Dec-2022 |
| Publisher: | American Journal of Medicine and Medical Sciences |
| Abstract: | Closed isolated traumatic brain injury (ТBI) is a major medical and social problem due to its high prevalence, high rates of mortality and disability, as well as the economic costs of treatment, rehabilitation and social assistance to victims [1]. Considering the severity of this disease and the insufficient effectiveness of conventional methods of treatment, we studied the effectiveness of the drug Kallidinogenase (tissue kallikrein) in complex therapy in patients with closed isolated traumatic brain injury. |
| URI: | http://repository.tma.uz/xmlui/handle/1/6201 |
| Appears in Collections: | Thesis, Articles |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 128.pdf | Kallidinogenase (Tissue Kallikrien) in Complex Therapy in Patients with Isolated Closed Traumatic Brain Injury | 294.45 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.